Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Version of Record online: 17 SEP 2012
Copyright © 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
EMBO Molecular Medicine
Volume 4, Issue 10, pages 1032–1042, October 2012
How to Cite
Hartkoorn, R. C., Sala, C., Neres, J., Pojer, F., Magnet, S., Mukherjee, R., Uplekar, S., Boy-Röttger, S., Altmann, K.-H. and Cole, S. T. (2012), Towards a new tuberculosis drug: pyridomycin – nature's isoniazid. EMBO Mol Med, 4: 1032–1042. doi: 10.1002/emmm.201201689
- Issue online: 2 OCT 2012
- Version of Record online: 17 SEP 2012
- Manuscript Accepted: 30 JUL 2012
- Manuscript Revised: 26 JUL 2012
- Manuscript Received: 29 JUN 2012
- Funded Access
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.